PRPH — ProPhase Labs, Inc.

Healthcare • Drug Manufacturers - Specialty & Generic

$0.38
-0.02 (—%)

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. The company also provides contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; SARS-CoV-2 (COVID-19) and COVID-19 viral mutation polymerase chain reaction tests through saliva and nasal swab methods; and other respiratory pathogen panel molecular testing services, as well as personal genomics products and services. It serves national chain drug, internet-based, and various regional retailers. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Company

Ticker
PRPH
Exchange
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
US
CEO
Ted William Karkus
Employees
96
Website
www.prophaselabs.com

Price

Showing ALL history. Source: FMP “historical price full”.

Prev Close
$0.41
Day High
$0.41
Day Low
$0.38
52w High
$2.44
52w Low
$0.22
Volume
770,635
Avg Volume
Beta
-0.605

Key Metrics

Market Cap
15.9M
P/E
P/B
P/S
EV/EBITDA
ROE
Net Margin
Div Yield
FCF/Share

* TTM/most recent where available